American investors might not have to trade in the company's ADSes in the future. Trading in AstraZeneca's (NASDAQ: AZN) ...

The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

AstraZeneca Plc’s shares rose after a report that Chief Executive Officer Pascal Soriot wants to move the British drugmaker’s ...

AstraZeneca’s chief executive has discussed shifting the company’s stock market listing to the US in a move that would deal a ...

(Reuters) -AstraZeneca CEO Pascal Soriot is considering moving the company's stock market listing to the U.S., the Times ...

ADRs added ~2% in the morning hours on Tuesday after The Times reported that CEO Sir Pascal Soriot has privately indicated ...

AstraZeneca chief executive Pascal Soriot is considering moving the company's stock exchange listing from the UK to the US – ...

Just days after President Donald Trump was elected in November, AstraZeneca unvei | AstraZeneca CEO Pascal Soriot is plotting ...

CEO Pascal Soriot has not hidden his annoyance at taxes and regulations the pharmaceutical firm have to navigate ...

Sky's James Sillars writes that a government, struggling for authority and prioritising economic growth, can not afford to ...

AstraZeneca chief executive Sir Pascal Soriot is reportedly considering the move due to growing frustration with the UK's ...